ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Healthcare Shares
Are healthy returns on the horizon for ASX 200 healthcare shares in 2023?
How to invest
Guess how much a $20k investment in these ASX 200 shares in 2013 is worth now
Dividend Investing
3 of the safest ASX dividend shares on Earth
Share Market News
Here are the top 10 ASX 200 shares today
How to invest
Looking to buy ASX shares for your kids this Christmas? I think these are great options
Broker Notes
Morgans names 2 more of the best ASX shares to buy in December
Growth Shares
Analysts name 2 excellent ASX growth shares to buy in December
How to invest
I'd aim for $1 million in retirement buying just 10 ASX 200 shares
Investing Strategies
'Dominant player': Expert urges buying ASX shares in 2 near-monopolies
Healthcare Shares
4 ASX 200 shares to buy in an unmissable sector: expert
Investing Strategies
3 ASX shares to buy in a sector ready to explode: expert
Growth Shares
Analysts name 2 excellent ASX 200 shares to buy now
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
